BHF vs WSFS

The Advanced Deterministic Scorecard reveals significant concerns, with a weak Piotroski F-Score of 3/9 indicating poor financial health, and the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a low P/E of 4.52 and a Price/Book of 0.58 suggesting potential value, the company faces declining revenue (YoY -10.10%) and erratic earnings performance, including large negative surprises. Strong operating margins and ROE of 16.18% are offset by high debt/equity of 1.47 and extremely weak technical and dividend signals. Analysts consensus is a hold, but the stock trades above the conservative Graham Number of $188.54, raising valuation concerns.

WSFS presents a stark dichotomy between strong earnings performance and weak fundamental health, highlighted by a weak Piotroski F-Score of 3/9. While the stock is attractively valued, trading below its Graham Number ($76.63) and showing a PEG ratio of 0.98, the low F-Score suggests deteriorating operational efficiency or financial quality. Earnings growth is impressive at 23.8% YoY with a consistent track record of beats, but this is contrasted by sluggish revenue growth and bearish insider sentiment. The stock is a value play with significant underlying health caveats that warrant a neutral stance.